Up | AC
Meeting of the Peripheral and Central Nervous
System Drugs Advisory Committee
December 06, 2007
Portions of this document have been determined to be exempt
from disclosure under the Freedom of Information Act (the FOIA) (5 U.S.C. §
These redacted portions will appear as white space on the screen or on the printed page.
FDA Briefing Material (pdf)
Prestwick Pharmaceuticals Inc.
The statements contained in this document(s) are those of
the product's sponsor, not FDA, and FDA does not necessarily agree with the
sponsor's statements. FDA has not made a final determination about the safety
or effectiveness of the product described in this document.
Briefing Material (pdf)